HEADER HYDROLASE 20-OCT-00 1G2M TITLE FACTOR XA INHIBITOR COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: COAGULATION FACTOR X; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN; COMPND 5 EC: 3.4.21.6; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: COAGULATION FACTOR X; COMPND 8 CHAIN: B; COMPND 9 FRAGMENT: DES-GLA FRAGMENT; COMPND 10 EC: 3.4.21.6 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 OTHER_DETAILS: BLOOD SERUM; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_COMMON: HUMAN; SOURCE 9 ORGANISM_TAXID: 9606; SOURCE 10 OTHER_DETAILS: BLOOD SERUM KEYWDS BLOOD COAGULATION, FACTOR XA, INHIBITOR COMPLEXES, SERINE PROTEINASE, KEYWDS 2 BLOOD COAGULATION CASCADE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR H.NAR REVDAT 4 13-NOV-24 1G2M 1 REMARK LINK REVDAT 3 24-FEB-09 1G2M 1 VERSN REVDAT 2 01-APR-03 1G2M 1 JRNL REVDAT 1 20-OCT-01 1G2M 0 JRNL AUTH H.NAR,M.BAUER,A.SCHMID,J.M.STASSEN,W.WIENEN,H.W.PRIEPKE, JRNL AUTH 2 I.K.KAUFFMANN,U.J.RIES,N.H.HAUEL JRNL TITL STRUCTURAL BASIS FOR INHIBITION PROMISCUITY OF DUAL SPECIFIC JRNL TITL 2 THROMBIN AND FACTOR XA BLOOD COAGULATION INHIBITORS. JRNL REF STRUCTURE V. 9 29 2001 JRNL REFN ISSN 0969-2126 JRNL PMID 11342132 JRNL DOI 10.1016/S0969-2126(00)00551-7 REMARK 2 REMARK 2 RESOLUTION. 3.02 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2000 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.02 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 18.51 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 944658.800 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.0 REMARK 3 NUMBER OF REFLECTIONS : 6609 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.218 REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.278 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 311 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.016 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 6623 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.19 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 960 REMARK 3 BIN R VALUE (WORKING SET) : 0.2820 REMARK 3 BIN FREE R VALUE : 0.3940 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 43 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.060 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2267 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 57.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.29000 REMARK 3 B22 (A**2) : -3.04000 REMARK 3 B33 (A**2) : 1.76000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM SIGMAA (A) : 0.42 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.49 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.72 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.090 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : PARR110.PRO REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : TOPR110.PRO REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1G2M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-NOV-00. REMARK 100 THE DEPOSITION ID IS D_1000012156. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-JAN-98 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6623 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.4 REMARK 200 DATA REDUNDANCY : 2.600 REMARK 200 R MERGE (I) : 0.12200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.70000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.85000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.60000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 39.85000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.70000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.60000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2740 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13650 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP B 346 REMARK 465 GLY B 347 REMARK 465 ASP B 348 REMARK 465 GLN B 349 REMARK 465 CYS B 350 REMARK 465 GLU B 351 REMARK 465 THR B 352 REMARK 465 SER B 353 REMARK 465 PRO B 354 REMARK 465 CYS B 355 REMARK 465 GLN B 356 REMARK 465 ASN B 357 REMARK 465 GLN B 358 REMARK 465 GLY B 359 REMARK 465 LYS B 360 REMARK 465 CYS B 361 REMARK 465 LYS B 362 REMARK 465 ASP B 363 REMARK 465 GLY B 364 REMARK 465 LEU B 365 REMARK 465 GLY B 366 REMARK 465 GLU B 367 REMARK 465 TYR B 368 REMARK 465 THR B 369 REMARK 465 CYS B 370 REMARK 465 THR B 371 REMARK 465 CYS B 372 REMARK 465 LEU B 373 REMARK 465 GLU B 374 REMARK 465 GLY B 375 REMARK 465 PHE B 376 REMARK 465 GLU B 377 REMARK 465 GLY B 378 REMARK 465 LYS B 379 REMARK 465 ASN B 380 REMARK 465 CYS B 381 REMARK 465 GLU B 382 REMARK 465 LEU B 383 REMARK 465 PHE B 384 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 74 CG CD OE1 OE2 REMARK 470 GLN A 75 CG CD OE1 NE2 REMARK 470 ASN B 405 CG OD1 ND2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG A 63 CB CG CD NE CZ NH1 NH2 REMARK 480 ARG A 150 CB CG CD NE CZ NH1 NH2 REMARK 480 LYS A 243 NZ REMARK 480 ARG A 245 O CB CG CD NE CZ NH1 REMARK 480 ARG A 245 NH2 OXT REMARK 480 LYS B 387 CB CG CD CE NZ REMARK 480 LEU B 391 CB CG CD1 CD2 REMARK 480 ASP B 392 OD1 OD2 REMARK 480 HIS B 401 CG ND1 CD2 CE1 NE2 REMARK 480 GLU B 402 OE2 REMARK 480 GLU B 403 CG CD OE1 OE2 REMARK 480 GLN B 404 CB CG CD OE1 NE2 REMARK 480 ASN B 405 CA C O CB REMARK 480 ARG B 413 NH2 REMARK 480 ASP B 419 OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ALA A 128 N - CA - C ANGL. DEV. = -18.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 48 -167.25 -163.73 REMARK 500 GLN A 61 21.45 -76.99 REMARK 500 ALA A 61A 134.87 -170.79 REMARK 500 GLU A 74 -77.14 -76.34 REMARK 500 GLU A 77 30.30 -81.34 REMARK 500 ASN A 92 -8.45 -58.42 REMARK 500 PRO A 124 -155.37 -93.21 REMARK 500 TRP A 127 72.19 90.43 REMARK 500 ALA A 128 -69.36 166.70 REMARK 500 SER A 130 138.45 106.99 REMARK 500 THR A 131 -58.86 77.59 REMARK 500 PHE A 141 50.52 -103.81 REMARK 500 HIS A 145 -1.43 -152.43 REMARK 500 GLU A 147 117.35 71.28 REMARK 500 ASP A 189 152.86 178.26 REMARK 500 LYS A 204 -75.83 72.89 REMARK 500 ASP A 205 -10.61 -146.71 REMARK 500 VAL A 213 108.92 -53.23 REMARK 500 SER A 214 -71.10 -97.27 REMARK 500 THR A 244 107.77 77.50 REMARK 500 LYS B 387 177.35 174.35 REMARK 500 LEU B 388 112.43 86.50 REMARK 500 ASP B 392 57.41 -175.14 REMARK 500 ASN B 393 17.97 57.93 REMARK 500 GLN B 398 -116.12 -139.21 REMARK 500 GLN B 404 -73.18 70.70 REMARK 500 ASN B 405 -18.40 -152.46 REMARK 500 VAL B 408 97.94 53.91 REMARK 500 LYS B 422 -45.66 -135.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 999 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 70 OD1 REMARK 620 2 ASN A 72 O 76.5 REMARK 620 3 GLN A 75 O 161.4 84.9 REMARK 620 4 GLU A 77 OE1 117.6 106.6 66.0 REMARK 620 5 GLU A 80 OE1 78.0 134.1 117.3 119.0 REMARK 620 6 GLU A 80 OE2 109.8 173.0 88.6 68.1 51.8 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 999 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE R11 A 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1G2L RELATED DB: PDB REMARK 900 1G2L IS FACTOR XA INHIBITOR COMPLEX. DBREF 1G2M A 16 245 UNP P00742 FA10_HUMAN 235 469 DBREF 1G2M B 385 439 UNP P00742 FA10_HUMAN 86 179 SEQRES 1 A 235 ILE VAL GLY GLY GLN GLU CYS LYS ASP GLY GLU CYS PRO SEQRES 2 A 235 TRP GLN ALA LEU LEU ILE ASN GLU GLU ASN GLU GLY PHE SEQRES 3 A 235 CYS GLY GLY THR ILE LEU SER GLU PHE TYR ILE LEU THR SEQRES 4 A 235 ALA ALA HIS CYS LEU TYR GLN ALA LYS ARG PHE LYS VAL SEQRES 5 A 235 ARG VAL GLY ASP ARG ASN THR GLU GLN GLU GLU GLY GLY SEQRES 6 A 235 GLU ALA VAL HIS GLU VAL GLU VAL VAL ILE LYS HIS ASN SEQRES 7 A 235 ARG PHE THR LYS GLU THR TYR ASP PHE ASP ILE ALA VAL SEQRES 8 A 235 LEU ARG LEU LYS THR PRO ILE THR PHE ARG MET ASN VAL SEQRES 9 A 235 ALA PRO ALA CYS LEU PRO GLU ARG ASP TRP ALA GLU SER SEQRES 10 A 235 THR LEU MET THR GLN LYS THR GLY ILE VAL SER GLY PHE SEQRES 11 A 235 GLY ARG THR HIS GLU LYS GLY ARG GLN SER THR ARG LEU SEQRES 12 A 235 LYS MET LEU GLU VAL PRO TYR VAL ASP ARG ASN SER CYS SEQRES 13 A 235 LYS LEU SER SER SER PHE ILE ILE THR GLN ASN MET PHE SEQRES 14 A 235 CYS ALA GLY TYR ASP THR LYS GLN GLU ASP ALA CYS GLN SEQRES 15 A 235 GLY ASP SER GLY GLY PRO HIS VAL THR ARG PHE LYS ASP SEQRES 16 A 235 THR TYR PHE VAL THR GLY ILE VAL SER TRP GLY GLU GLY SEQRES 17 A 235 CYS ALA ARG LYS GLY LYS TYR GLY ILE TYR THR LYS VAL SEQRES 18 A 235 THR ALA PHE LEU LYS TRP ILE ASP ARG SER MET LYS THR SEQRES 19 A 235 ARG SEQRES 1 B 94 ASP GLY ASP GLN CYS GLU THR SER PRO CYS GLN ASN GLN SEQRES 2 B 94 GLY LYS CYS LYS ASP GLY LEU GLY GLU TYR THR CYS THR SEQRES 3 B 94 CYS LEU GLU GLY PHE GLU GLY LYS ASN CYS GLU LEU PHE SEQRES 4 B 94 THR ARG LYS LEU CYS SER LEU ASP ASN GLY ASP CYS ASP SEQRES 5 B 94 GLN PHE CYS HIS GLU GLU GLN ASN SER VAL VAL CYS SER SEQRES 6 B 94 CYS ALA ARG GLY TYR THR LEU ALA ASP ASN GLY LYS ALA SEQRES 7 B 94 CYS ILE PRO THR GLY PRO TYR PRO CYS GLY LYS GLN THR SEQRES 8 B 94 LEU GLU ARG HET CA A 999 1 HET R11 A 1 32 HETNAM CA CALCIUM ION HETNAM R11 4-{[1-METHYL-5-(2-METHYL-BENZOIMIDAZOL-1-YLMETHYL)-1H- HETNAM 2 R11 BENZOIMIDAZOL-2-YLMETHYL]-AMINO}-BENZAMIDINE FORMUL 3 CA CA 2+ FORMUL 4 R11 C25 H25 N7 HELIX 1 1 ALA A 55 GLN A 61 5 7 HELIX 2 2 ASP A 164 SER A 172 1 9 HELIX 3 3 PHE A 234 LYS A 243 1 10 HELIX 4 4 ASP B 392 CYS B 396 5 5 SHEET 1 A 7 ALA A 81 LYS A 90 0 SHEET 2 A 7 LYS A 65 VAL A 68 -1 N VAL A 66 O HIS A 83 SHEET 3 A 7 GLN A 30 ILE A 34 -1 O LEU A 32 N ARG A 67 SHEET 4 A 7 GLY A 40 ILE A 46 -1 N PHE A 41 O LEU A 33 SHEET 5 A 7 TYR A 51 THR A 54 -1 N LEU A 53 O THR A 45 SHEET 6 A 7 ALA A 104 LEU A 108 -1 O ALA A 104 N THR A 54 SHEET 7 A 7 ALA A 81 LYS A 90 -1 N GLU A 86 O ARG A 107 SHEET 1 B 8 GLN A 20 GLU A 21 0 SHEET 2 B 8 LYS A 156 VAL A 163 -1 N MET A 157 O GLN A 20 SHEET 3 B 8 MET A 180 ALA A 183 -1 O CYS A 182 N VAL A 163 SHEET 4 B 8 GLY A 226 LYS A 230 -1 O GLY A 226 N ALA A 183 SHEET 5 B 8 THR A 206 GLY A 216 -1 O ILE A 212 N THR A 229 SHEET 6 B 8 PRO A 198 PHE A 203 -1 N HIS A 199 O GLY A 211 SHEET 7 B 8 THR A 135 GLY A 140 -1 N ILE A 137 O VAL A 200 SHEET 8 B 8 LYS A 156 VAL A 163 -1 O LYS A 156 N GLY A 140 SHEET 1 C 2 PHE B 399 CYS B 400 0 SHEET 2 C 2 CYS B 409 SER B 410 -1 N SER B 410 O PHE B 399 SHEET 1 D 2 TYR B 415 LEU B 417 0 SHEET 2 D 2 CYS B 424 PRO B 426 -1 N ILE B 425 O THR B 416 SSBOND 1 CYS A 22 CYS A 27 1555 1555 2.04 SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.02 SSBOND 3 CYS A 122 CYS B 432 1555 1555 2.02 SSBOND 4 CYS A 168 CYS A 182 1555 1555 2.03 SSBOND 5 CYS A 191 CYS A 220 1555 1555 2.03 SSBOND 6 CYS B 389 CYS B 400 1555 1555 2.03 SSBOND 7 CYS B 396 CYS B 409 1555 1555 2.03 SSBOND 8 CYS B 411 CYS B 424 1555 1555 2.02 LINK OD1 ASP A 70 CA CA A 999 1555 1555 2.42 LINK O ASN A 72 CA CA A 999 1555 1555 2.18 LINK O GLN A 75 CA CA A 999 1555 1555 2.57 LINK OE1 GLU A 77 CA CA A 999 1555 1555 3.36 LINK OE1 GLU A 80 CA CA A 999 1555 1555 2.80 LINK OE2 GLU A 80 CA CA A 999 1555 1555 1.76 SITE 1 AC1 5 ASP A 70 ASN A 72 GLN A 75 GLU A 77 SITE 2 AC1 5 GLU A 80 SITE 1 AC2 14 HIS A 57 THR A 98 TYR A 99 PHE A 174 SITE 2 AC2 14 ASP A 189 ALA A 190 CYS A 191 SER A 195 SITE 3 AC2 14 SER A 214 TRP A 215 GLY A 216 GLY A 218 SITE 4 AC2 14 CYS A 220 GLY A 226 CRYST1 57.400 73.200 79.700 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017422 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013661 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012547 0.00000